# OnCo record nct07579234 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07579234/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07579234", "NCT07579234" ;
  schema:name "A Multicenter, Randomized, Open-label, Parallel-group, Controlled, Superiority Phase III Clinical Study Comparing the Efficacy and Safety of F182112 Versus Standard of Care in Patients With Relapsed or Refractory Multiple Myeloma"@en ;
  schema:description "A phase 3 trial testing F182112 in multiple myeloma, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07579234/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07579234> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2026-01-25" ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/>, <https://onco.cc/cancers/myeloma-relapsed-refractory/> ;
  onco:drugs <https://onco.cc/drugs/f182112/> ;
  onco:companies <https://onco.cc/companies/shandong-new-time-pharmaceutical/> .